Trauma and orthopaedic team members' mental health during the COVID-19 pandemic: results of a UK survey

• Published in: Bone & joint open Vol. 1; no. 6; pp. 316 - 325
• Main Authors: Thakrar, Amit, Raheem, Ali, Chui, Karen, Karam, Edward, Wickramarachchi, Lilanthi, Chin, Kuen
• Format: Journal Article
• Language: English
• Published: England The British Editorial Society of Bone and Joint Surgery 01.06.2020
• Subjects: General Orthopaedics; Covid 19; anxiety; orthopaedics; depression; pandemic; mental health
• ISSN: 2633-1462; 2633-1462
• DOI: 10.1302/2046-3758.16.BJO-2020-0053.R1

Healthcare systems have been rapidly restructured to meet COVID-19 demand. Clinicians are working to novel clinical guidelines, treating new patient cohorts and working in unfamiliar environments. Trauma and orthopaedics (T&O) has experienced cancellation of routine clinics and operating, with redistribution of the workload and human resources. To date, no studies have evaluated the mental health impact of these changes on the T&O workforce. We report the results of a novel survey on the impact of the pandemic on the mental health of our orthopaedic workforce and the contributory factors. A 20-question survey-based cross-sectional study of orthopaedic team members was conducted during the COVID-19 pandemic. The primary objective was to identify the impact of the pandemic on mental health in the form of major depressive disorder (MDD) and general anxiety disorder (GAD). The survey incorporated the patient health questionnaire (PHQ-2), which is validated for screening of MDD, and the generalized anxiety disorder questionnaire (GAD-2), which is validated for screening of GAD. There were 62 respondents (18 females and 44 males). As compared to the general population, we noted a greater estimated prevalence of GAD (17.7% vs 5.9%, p = 0.0009297) and MDD (19.4% vs 3.3%, p = 0.0000007731). The prevalence of MDD symptoms was greatest among senior house officers (SHOs) (p = 0.02216). Female respondents scored higher for symptoms of MDD (p = 0.03583) and GAD (p = 0.0001086). Those identifying as 'Black, African, Caribbean or Black British' displayed a higher prevalence of GAD symptoms (p = 0.001575) and felt least supported at work (p = 0.001341). Our study, in the first of its kind, shows a significant prevalence of GAD and MDD in the workforce. We found that SHOs, females and those of Black, African, Caribbean, or Black British origin were disproportionately affected. Action should be taken to help prevent adverse mental health outcomes for our colleagues during the pandemic.Cite this article: 2020;1-6:316-325.